As USP30 antagonizes mitophagy through ubiquitination, its inhibition has been proposed as a novel therapeutic strategy to enhance mitochondrial turnover and clear damaged mitochondrial proteins, providing a much-needed strategy to improve outcomes in PD and other neurodegenerative disorders. The gene discussed is USP30; the disease is Parkinson disease.